FDA Approves First Drug Aimed at Preventing Migraines
FRIDAY, May 18, 2018 (HealthDay News) — The millions of Americans who suffer from migraine may have a new source of hope — the first drug aimed at preventing the headaches gained U.S. Food and Drug Administration approval on Thursday. Researchers have found that the injected drug, called Aimovig (erenumab),Continue Reading